DNA-based vaccines;Les vaccins a base d'ADN

Medecine Therapeutique

Volumn 6, Issue 4, 2000, Pages 310-318

  Michel, Marie Louise ^a   Loirat, Delphine ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA VACCINE;

ALLERGY; ANTIGEN PRESENTATION; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; IMMUNOSTIMULATION; INFECTION; REVIEW; VACCINATION;

EID: 0034125851     PISSN: 12646520     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Wolff J.A., et al. 1990. Direct gene transfer into mouse muscle in vivo. Science 247 : 1465-1468.
2. Tang D., De Vit M., Johnston S.A. 1992. Genetic immunization is a simple method for eliciting an immune response. Nature 356 : 152-154.
3. Ulmer J.B., et al. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259 : 1745-1749.
4. Spooner R.A., Deonarain M.P., Epenetos A.A. 1995. DNA vaccination for cancer treatment. Gene Ther 2 : 173-180.
5. Wang B., et al. 1993. DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates. DNA Cell Biol 12 : 799-805.
6. Davis H.L., Michel M.L., Whalen R.G. 1993. DNA based immunization for hepatitis B induces continuous secretion of antigen and high levels of circulating antibody. Hum Molec Genet 2 : 1847-1851.
7. Xiang Z.Q., Spitalnik S., Tran M., Wunner W.H., Cheng J., Ertl H.C.J. 1994. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199? : 132-140.
8. Cox G.J., Zamb T.J., Babiuk L.A. 1993. Bovine herpesvirus 1 : immune responses in mice and cattle injected with plasmid DNA. J Virol 67 : 5664-5667.
9. Huygen K., et al. 1996. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med 2 : 893-898.
10. Tascon R.E., Colston M.J., Ragno S., Stavropoulos E., Gregory D., Lowrie D.B. 1996. Vaccination against tuberculosis by DNA injection. Nat Med 2 : 888-892.
11. Hoffman S.L., et al. 1995. Nucleic acid malaria vaccines. Current status and potential. Ann N Y Acad Sci 772 : 88-94.
12. Condon C., Watkins S.C., Celluzzi C.M., Thompson K., Falo L.D. Jr. 1996. DNA-based immunization by in vivo transfection of dendritic cells. Nat Med 2 : 1122-1128.
13. Michel M.L., Davis H.L., Schleef M., Mancini M., Tiollais P., Whalen R.G. 1995. DNA-mediated immunization to the hepatitis B surface antigen in mice : aspects of the humoral response mimic hepatitis B viral infection in humans. Proc Natl Acad Sci USA 92 : 5307-5311.
14. Barnett S.W., et al. 1997. Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit. Vaccine 15 : 869-873.
15. Torres C.A.T., Iwasaki A., Barber B., Robinson H.L. 1997. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J. Immunol. 158 : 4529-4532.
16. Casares S., Inaba K., Brumeanu T.D., Steinman R.M., Bona C.A. 1997. Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope. J Exp Med 186 : 1481-1486.
17. Ulmer J.B., Deck R.R., Dewitt C.M., Donnelly J.J., Liu M.A. 1996. Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells : antigen presentation by non-muscle cells. Immunology 89 : 59-67.
18. Davis H.L., Milian C.L., Watkins B.C. 1997. Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA. Gene Ther 4 : 181-188.
19. Akbari O., Panjwani N., Garcia S., Tascone R., Lowrie D., Stockinger B. 1999. DNA vaccination : transfection and activation of dendritic cells as key events for immunity. J Exp Med 189 : 169-177.
20. Roman M., et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nature Medicine 3 : 849-854.
21. Krieg A.M., et al. 1998. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc Natl Acad Sci USA 95 : 12631-12636.
22. Inchauspe G. 1999. DNA vaccine strategies for hepatitis C. J Hepatol 30 : 339-346.
23. Hinkula J., et al. 1997. Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type 1 regulatory genes. J Virol 71 : 5528-5539.
24. Wild J., et al. 1998. Polyvalent vaccination against hepatitis B surface and core antigen using a dicistronic expression plasmid. Vaccine 16 : 353-360.
25. Suhrbier A. 1997. Multi-epitope DNA vaccines. Immunol Cell Biol 75 : 402-408.
26. Barry M.A., Lai W.C., Johnston S.A. 1995. Protection against mycoplasma infection using expression-library immunization. Nature 377 : 632-635.
27. Mancini M., Hadchouel M., Davis H.L., Whalen R.G., Tiollais P., Michel M.L. 1996. DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state. Proc Natl Acad Sci USA 93 : 12496-12501.
28. Schirmbeck R., Bohm W., Reimann J. 1996. DNA vaccination primes MHC class I-restricted, simian virus 40 large tumor antigen-specific CTL in H-2d mice that reject syngeneic tumors. J Immunol 157 : 3550-3558.
29. Horton H.M., Anderson D., Hernandez P., Barnhart K.M., Norman J.A., Parker S.E. 1999. A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon alpha. Proc Natl Acad Sci USA 96 : 1553-1558.
30. Hsu C.H., et al. 1996. Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization. Nat Med 2 : 540-544.
31. Chow Y.H., Huang W.L., Chi W.K., Chu Y.D., Tao M.H. 1997. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J Virol 71 : 169-178.
32. Okada E., et al. 1997. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte- macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J Immunol 159 : 3638-3647.
33. Iwasaki A., Stiernholm B.J., Chan A.K., Berinstein N.L., Barber B.H. 1997. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J Immunol 158 : 4591-4601.
34. Tobery T.W., Siliciano R.F. 1997. Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization. J Exp Med 185 : 909-920.
35. Boyle J.S., Brady J.L., Lew A.M. 1998. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature 392 : 408-411.
36. Nichols W.W., Ledwith B.J., Manam S.V., Troilo P.J. 1995. Potential DNA vaccine integration into host cell genome. Ann N Y Acad Sci 772 : 30-39.
37. MacGregor R.R., et al. 1998. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection : safety and host response. J Infect Dis 178 : 92-100.
38. Mor G., et al. 1997. Do DNA vaccines induce autoimmune disease ? Hum Gene Ther 8 : 293-300.
39. Wang R., et al. 1998. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282 : 476-480.
40. Calarota S , et al. 1998. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients. Lancet 351 : 1320-1325.